Form 10-Q NEVRO CORP For: Jun 30

Go back to Form 10-Q NEVRO CORP For: Jun 30

Citi Moves to Sidelines Nevro Corp (NVRO), Moves to Neutral, 'uncertainty remains high'

August 8, 2024 4:41 PM EDT

Citi analyst Joanna Wuensch upgraded Nevro Corp (NYSE: NVRO) from Sell to Neutral with a price target of $6.89.

The analyst comments "With the 2Q24 print (link), we are upgrading NVRO to Neutral from Sell. While the quarter itself was fairly benign, the... More

Nevro Corp (NVRO) PT Lowered to $7 at Jefferies

August 7, 2024 8:00 AM EDT

Jefferies analyst Matthew Taylor lowered the price target on Nevro Corp (NYSE: NVRO) to $7.00 (from $10.00) while maintaining a Underperform rating.

The analyst comments "NVRO reported 2Q revs of $104 MM (+4.2% xfx), vs cons $107 MM. EBITDA was $3 MM vs cons -$3 MM. NVRO... More

Nevro Corp (NVRO) PT Lowered to $7 at RBC Capital

August 7, 2024 7:04 AM EDT

RBC Capital analyst Shagun Singh lowered the price target on Nevro Corp (NYSE: NVRO) to $7.00 (from $16.00) while maintaining a Sector Perform rating.

The analyst comments "NVRO delivered a Q2'24 miss on sales while EPS beat, and FY24 revenue guidance... More